Search results
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 20 hours agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 hour agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced ...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 1 day agoThe oncology market is known for its strong pricing power, with cancer drugs typically carrying high price tags and significant margins. While Pfizer's...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoLater this month, the Food and Drug Administration will consider approving Moderna...in babies and...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 4 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors ...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 3 days agocancer targeted mid-year 2024Targeting initial Phase 2 expansion for IDE161 in HRD solid tumors and Phase 1 FPI for IDE161 in combination with Merck's anti-PD-1 therapy < ...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar ...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 3 days agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
Q1 2024 CytomX Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoThis overall structure is somewhat similar to Amgen's tocilizumab that has shown impressive results in small cell lung cancer, shown on the right of this slide is a recap ...
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3...
Morningstar· 2 days agoFN Media Group News Commentary - There is much activity in finding better ways in mitigating muscle loss for the cancer patients… many clinical studies are looking for elite ...
